Home › News › Pharma Industry News › Archive

Pharmaceutical Industry News Archive

Get news By email or subscribe to our News feeds.

All News Consumer Pharma New Drugs Pipeline Clinical Trials

October 2007

October 1

Teva Announces Court of Appeals Denies Novartis' Emergency Motion on Generic Famvir Eisai Announce Application to Appeal NICE Judicial Review Verdict AstraZeneca Appoints Chief Financial Officer Kissei and Eisai Sign a License Agreement to Develop and Commercialize Glufast, a Rapid-acting Insulin Secretagogue in China Mitsubishi Tanabe Pharma Corporation Announces Its Establishment Roche Confirms Site Development Plans: Go-Ahead for Office High-Rise Shire to Support Appeal Against Outcome of Judicial Review of NICE Guidance Which Denies Newly Diagnosed Patients with Mild Alzheimer's Disease Access to Drugs on the NHS Bristol-Myers Squibb to Pay More Than $515 Million to Resolve Allegations of Illegal Drug Marketing and Pricing Mylan Announces Extension of Tender Offers for Its 5.750% Senior Notes due 2010 and 6.375% Senior Notes due 2015 Amgen Provides Update on Late-Stage and Early-Stage Pipeline at UBS Global Life Sciences Conference Addex Pharmaceuticals Announces ADX10061 Phase IIa Smoking Cessation Data Daiichi Sankyo Quietly Grows While Other Pharmaceutical Firms Downsize FivePrime Achieves Target Discovery Milestone With Boehringer Ingelheim Chemizon Announces Research Collaboration Expansion With Takeda GE and Lilly Announce Research Collaboration to Co-Develop Molecular In Vitro Diagnostics for Cancer Treatments AmerisourceBergen Acquires Bellco Health for $190 Million PDL BioPharma to Actively Seek Sale of Entire Company or Its Key Assets

October 4

More than 40% of US Physicians Report Improved Services from Pharma, with Merck Rated Highest on Delivering Quality Sales and Service Experiences Dr. Martin Mackay Named President of Pfizer Global Research and Development Children's Aching Stomachs: New Research Finds Young Children are Increasingly Using Medications to Treat Gastrointestinal Ailments Amgen to Postpone Indefinitely Its Plans for a Manufacturing Facility in Ireland GSK Seeks Prequalification for Cervarix from the World Health Organization After Obtaining Marketing Approval in Europe Announcement of the Launch of Geninax Tablet, an Oral New-Type Quinolone Antibacterial Agent, in Japan Novartis Pharmaceuticals Canada Inc. Complies with Request from Health Canada to Withdraw Prexige (lumiracoxib) in Canada Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc. FDA Announces Initiative to Bolster Generic Drug Program FDA Seeks Nominations for Reagan-Udall Foundation FDA Takes Next Step in Transformation of its Center for Drug Evaluation and Research Bioject Announces Roche and Trimeris Update on the Use of Fuzeon with Biojector 2000

October 10

GlaxoSmithKline and Synta Pharmaceuticals Announce Development and Commercialization Collaboration for STA-4783 in Oncology Bioenvision and Genzyme File Petition in Delaware Court Health Care Merger and Acquisition Activity Strong in Third Quarter 2007, Year Already Second-Largest Ever in Health Care M&A According to New Report from Irving Levin Associates, Inc. Medication Shows Promise as a Treatment for Alcohol Dependence DARA BioSciences and Point Therapeutics Announce Merger Plans Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies Iowa AG Sues 78 Drug Companies for Overcharging Iowa Medicaid Sales of Etimicin Sulfate to Expand Nationwide as Government Restriction is Lifted Taisho Revises Earnings Forecasts for FY2007 First Half and Full Year Lupin Acquires in Japan Delaware Court Approves Bioenvision, Genzyme Joint Petition

October 15

Pharmacopeia Acquires Selective Androgen Receptor Modulator ('SARM') Program from Bristol-Myers Squibb FDA Removes Partial Hold on Telcyta Clinical Development Pfizer Engages with Nation's Physicians Through Sermo to Improve Patient Care Orexo to Acquire Biolipox - Building a Specialty Pharma Company Driven by Innovation Biogen Idec Issues Statement HealthiNation Delivers On Demand Health Programming to Verizon FiOS TV Subscribers European Medicines Agency Sees Strong Level of Applications in 2007 Biopure Announces Expanded Clinical Program to Target Anemia Sartorius Sells Hydrodynamic Bearings Business to the British Smiths Group Microarray Sequence Capture Speeds Large-Scale Resequencing of Targeted Genomic Regions Celera Completes Acquisition of Berkeley HeartLab, Inc. Agendia Acquires Rights to the Discovery of a Major Drug Resistance Mechanism in Breast Cancer Potentially Leading to a Herceptin Sensitivity Test

October 16

Camelot Ventures Sells RealAge to Hearst Magazines Johnson & Johnson Reports 2007 Third-Quarter Results: Sales of $15.0 Billion Increased 12.7%; EPS was $.88, Including Special Charges; Excluding Special Charges, EPS was $1.06 * Wyeth to Appeal Nevada Hormone Therapy Trial Verdict Genentech Announces Third Quarter 2007 Results Strong Sales Growth in the First Nine Months of 2007 - Full-year Outlook and Core Earnings Per Share Target Reaffirmed Forest Laboratories Reports Earnings Per Share of $0.71 for Q2'08 Including $0.15 Charge Net of Tax for Licensing Charge Thomson Scientific Publishes 'Who Is Making The Biggest Splash?' - A Quarterly Review of Scientific Literature on Drugs and Therapies From April - June 2007 Repros Provides Update for Regulatory Program Associated with Androxal Development Canon Communications Successfully Launches Medical Design & Manufacturing (MD&M) Event in Northern California OSI Pharmaceuticals Provides Additional Information About US Sales of Tarceva Edgeline Holdings to Close on Its Acquisition of Intertech Bio FDA MedWatch: Byetta (exenatide) and Postmarketing Reports of Acute Pancreatitis

October 18

Baxter Reports Strong Third Quarter Sales and Earnings Lilly Delivers Strong Third-Quarter Results Lilly and MacroGenics Announce Licensing and Collaboration Agreement Wyeth Reports Earnings Results for the 2007 Third Quarter and First Nine Months Novartis Delivers Record Earnings in First Nine Months of 2007 Thanks to Strong Operational Performance and Divestment Gains Pfizer Reports Third-Quarter 2007 Results; Reconfirms 2007 and 2008 Revenue and Adjusted Diluted EPS Guidance Aspreva to be Acquired by Galenica For US$915 Million IDEX Corporation Acquires Isolation Technologies in a Strategic Expansion of Its Health and Science Technologies Segment inVentiv Health Provides Sales Teams Contract Update EPO Announces Symbicort European Combination Patent Decision Dong-A Pharmaceutical Co Ltd (000640 KS) Calls on Kang-Korea Alcohol Nominees at October 31 EGM to Disclose Any Agreements or Understandings They Have Regarding Their Possible Service as Dong-A Directors

October 23

Biogen Idec Reports Third Quarter 2007 Results Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business GlaxoSmithKline and Tolerx Form Worldwide Collaboration for Development and Commercialization of Novel Medication Genzyme Launches Cholestagel in Europe ASCO and ASH Release Updated Guideline on the Use of Chemotherapy-Related Anemia Treatments in Cancer Patients Update Regarding Clinical Trials of Merck's HIV Vaccine Candidate Statement by Merck & Co., Inc. Regarding FDA Nonprescription Advisory Committee Review of Mevacor (lovastatin) Two Million Consumers Commit to Healthier Weight-Loss Approach with alli Delcath Voluntarily Defers Accrual in Clinical Trials Paramount Stockholders Approve Acquisition of Chem Rx Spanish Appellate Court Rules in Pfizer's Favor, Upholds Lipitor Patent Asuragen Enters Oncology Collaboration with Merck to Develop Pharmacogenomic Tests Roche Considering Legal Options In Patent Litigation Case Jury Rules Roche Infringes Amgen's EPO Patents

October 25

Bristol-Myers Squibb Company Reports Financial Results for the Third Quarter and First Nine Months of 2007 FDA and Cephalon Notify Healthcare Professionals of Updates to the Warnings Section of the Prescribing Information for Provigil (modafinil) Study Protocols Will be Amended in Two Small Early-Phase Prasugrel Studies ImClone Systems Reports Third Quarter 2007 Financial Results Shire Launches Clinical Study Results Website Amgen's Third Quarter 2007 Adjusted Earnings Per Share Increased 4 Percent to $1.08 Elan Reports Third Quarter 2007 Financial Results Genzyme and Sunway to Collaborate on Gene Therapy Program in China Novavax and Allergan Terminate Manufacturing Supply Agreement for Estrasorb Alcon's Third Quarter Sales Rise 11.0 Percent PerkinElmer Announces Expiration of Hart-Scott-Rodino Waiting Period of Proposed ViaCell Acquisition Barr Confirms Filing an Application With a Paragraph IV Certification for Patanol Ophthalmic Solution, 0.1% FDA Issues an Early Communication about an Ongoing Safety Review for Aprotinin Injection (marketed as Trasylol)

October 26

I-Flow Announces Closing of InfuSystem Transaction NovaBay Pharmaceuticals Prices Initial Public Offering of Common Stock Kosan to Reacquire Epothilone Program From Roche Pfizer Announces Retirement of Vice Chairman David L. Shedlarz Tapestry Announces Strategy to Focus on TPI 287 Clinical Program Daiichi Sankyo Announces the Revisions of Financial Forecasts for FY2007 Cortex to Provide Shareholder Update and Host Conference Call on October 31, 2007 Aviation Upgrade Technologies Enters into Merger Agreement with OncoVista, Inc. Collexis Holdings Acquires SyynX Solutions, Expands Application Portfolio Solvay: Nine Months 2007 Results Former GlaxoSmithKline Executive to Lead UNC Drug Discovery Center FDA Establishes a Pediatric Review Committee to Consult on General Review of Pediatric Information Submitted by Sponsors Warburg Pincus Completes Acquisition of Bausch & Lomb Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline

October 29

Kyowa Hakko Interim Operating Income up 25.2% ChemGenex Announces Strategic Restructuring of Company to Focus on Late-Stage Cancer Portfolio Takeda Provides Update on Development Status of TAK-475, An Investigational Compound for Treatment of Hypercholesterolemia AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune Thallion Provides Update on Shigamabs Clinical Development and U.S. Regulatory Plan John Edwards Introduces Proposals To Stop Misleading Drug Marketing By Standing Up To Drug Companies Dalton Medicinal Chemistry Partners Achieves Milestone in Collaboration with Boehringer Ingelheim (Canada) Ltd. Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS CTI Announces the FDA Allows Long Term Use of ISA247 in Isotechnika Phase 2b Clinical Program for the Prevention of Rejection Following Kidney Transplantation GAO: Prescription Drugs: FDA Guidance and Regulations Related to Data on Elderly Persons in Clinical Drug Trials Sen. Grassley Seeks Transparency in FDA Review of Heart Health Risks with Diabetes Drug Pfizer to Appeal German Court Decision in Lipitor Patent Case; Company Notes That Ruling Has No Immediate Commercial Impact MedWatch - The FDA Safety Information and Adverse Event Reporting Program FDA MedWatch: Use of CellCept (mycophenolate mofetil) Associated with Increased Pregnancy Loss and Congenital Malformations

October 30

Lilly and Glenmark Pharmaceuticals Announce License Agreement Taisho and Pfizer Sign a Letter of Intent for Taisho's Schizophrenia Drug Candidate Teva Reports Third Quarter 2007 Results Bradley Pharmaceuticals Announces Definitive Merger Agreement with Nycomed for $20 Per Share in Cash Pharmos Restructures Operations in Israel Sepracor Inc. Announces Third Quarter 2007 Results and Planned Reduction in Operating Expenses for 2008 Roche Extends Tender Offer for Ventana Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development Quantum Genomics Corp Widens Net with Acquisition of Eurobiobiz SAS P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth Coco-Cola, Kellogg’s, Mattel and Takeda Pharmaceuticals Top the List of International Brands Guilty of Abusing Consumer Rights. Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock Offering Minnesota Hormone Therapy Lawsuit Dismissed Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc. Younger Adults Increasingly Treated for Heart Disease-related Conditions Phase Forward Acquires Green Mountain Logic, An Innovative Provider of Software for Managing Phase I Clinical Trials Genentech: Open Letter

Pharmaceutical Industry News Archive

More News Resources

Printable Version Email Recommend Tweet Save or Share
(web4)